Biocon LimitedNSE: BIOCON

Press Release May 13 2024

· Issued by Biocon Limited

Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated May 13, 2024, titled "Biocon Limited signs semi-exclusive distribution and supply deal for the commercialization of generic Saxenda�� (Liraglutide) in Mexico with Medix".

View Attachment

6ix hasn’t read this filing yet.

Biocon Limited on 6ix

In the deck

Earlier from Biocon

Later from Biocon

All Biocon news releases